These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1351547)

  • 21. Magnesium substitution in acute ischaemic heart syndromes.
    Feldstedt M; Boesgaard S; Bouchelouche P; Svenningsen A; Brooks L; Lech Y; Aldershvile J; Skagen K; Godtfredsen J
    Eur Heart J; 1991 Nov; 12(11):1215-8. PubMed ID: 1782952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive magnesium infusion therapy in acute myocardial infarction.
    Bhargava B; Chandra S; Agarwal VV; Kaul U; Vashishth S; Wasir HS
    Int J Cardiol; 1995 Nov; 52(2):95-9. PubMed ID: 8749868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravenous magnesium in acute myocardial infarct].
    Urek R; Halle J; Frank B; Goles T; Tomicić D; Mirat J; Kolevska-Kaniski T
    Lijec Vjesn; 1996; 118(11-12):279-81. PubMed ID: 9213716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Magnesium therapy in acute myocardial infarction].
    Landmark K; Urdal P
    Tidsskr Nor Laegeforen; 1992 Feb; 112(4):495-7. PubMed ID: 1553701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up after acute myocardial infarction in patients randomized to treatment with intravenous magnesium or intravenous propranolol in the acute phase.
    Abraham AS; Balkin J; Rosenmann D; Ilan M; Klutstein M; Zion MM
    Magnes Res; 1994 Dec; 7(3-4):273-6. PubMed ID: 7786690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnesium therapy in acute myocardial infarction.
    Visser PJ; Bredero AC; Hoekstra JB
    Neth J Med; 1995 Mar; 46(3):156-65. PubMed ID: 7731491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a place for magnesium in the treatment of acute myocardial infarction?
    Seelig MS; Elin RJ
    Am Heart J; 1996 Aug; 132(2 Pt 2 Su):471-7; discussion 496-502. PubMed ID: 8694006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of magnesium sulphate in patients with unstable angina. A double blind, randomized, placebo-controlled study.
    Redwood SR; Bashir Y; Huang J; Leatham EW; Kaski JC; Camm AJ
    Eur Heart J; 1997 Aug; 18(8):1269-77. PubMed ID: 9458419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of intravenous administration of SO4Mg in the acute phase of myocardial infarct].
    Pereira D; Pereira TG; Rabaçal C; Carvalho E; Linder J; Afonso JS; Pereira JN; Halpern MJ; Fernandes JS
    Rev Port Cardiol; 1990 Mar; 9(3):205-10. PubMed ID: 2390281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of the magnesium in coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction.
    MAGIC Steering Committee
    Am Heart J; 2000 Jan; 139(1 Pt 1):10-4. PubMed ID: 10618556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous intravenous infusion of magnesium sulfate after acute myocardial infarction.
    Abraham AS; Balkin J; Rosenmann D; Eylath U; Zion MM
    Magnes Trace Elem; 1990; 9(3):137-42. PubMed ID: 2248694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction.
    Horner SM
    Circulation; 1992 Sep; 86(3):774-9. PubMed ID: 1387591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of intravenous magnesium therapy in thrombolysis-ineligible acute myocardial infarction patients.
    Shechter M; Hod H; Rabinowitz B; Boyko V; Chouraqui P
    Cardiology; 2003; 99(4):205-10. PubMed ID: 12845247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.
    Domanski M; Antman EM; McKinlay S; Varshavsky S; Platonov P; Assmann SF; Norman J
    Control Clin Trials; 2004 Dec; 25(6):553-62. PubMed ID: 15588742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Magnesium therapy in acute myocardial infarction. New points of view].
    Landmark K; Abdelnoor M
    Tidsskr Nor Laegeforen; 1995 Aug; 115(18):2268-70. PubMed ID: 7652726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators.
    Flather M; Pipilis A; Collins R; Budaj A; Hargreaves A; Kolettis T; Jacob A; Millane T; Fitzgerald L; Cedro K
    Eur Heart J; 1994 May; 15(5):608-19. PubMed ID: 8055999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does magnesium therapy early in acute MI reduce mortality?
    Phillips J; Krist A
    J Fam Pract; 2003 Mar; 52(3):195, 199. PubMed ID: 12620172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
    Berger JS; Roe MT; Gibson CM; Kilaru R; Green CL; Melton L; Blankenship JD; Metzger DC; Granger CB; Gretler DD; Grines CL; Huber K; Zeymer U; Buszman P; Harrington RA; Armstrong PW
    Am Heart J; 2009 Dec; 158(6):998-1004.e1. PubMed ID: 19958867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.